{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Matthew%207%3A25%20Inc%20dba%20Thrive%20Pharmacy","name":"Matthew 7:25 Inc dba Thrive Pharmacy","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-06T17:12:03.374Z"},"count":1,"matches":[{"id":"ff50be88f5a93e09","posted_date":"2021-11-16","letter_issue_date":"2021-07-22","company_name":"Matthew 7:25 Inc dba Thrive Pharmacy","issuing_office":"Office of Pharmaceutical Quality Operations, Division II","subject":"Compounding Pharmacy/Adulterated Drug Products","canonical_url":"https://api.morvs.ai/fda-warning/ff50be88f5a93e09"}]}